Evidence map›Paper›PMID 28750812›Full record

ArticleMethods in enzymology2017

Expression and NMR Structural Studies of Isotopically Labeled Cannabinoid Receptor Type II.

Alexei Yeliseev, Klaus Gawrisch

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Methods in enzymology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Charting the Cannabis plant chemical space with computational metabolomics.Metabolomics : Official journal of the Metabolomic Society · 2024
    Article
  2. Tetrahydrocannabinol and dopamine D1 receptor.Frontiers in neuroscience · 2024
    Review
  3. Article
  4. Special issue for Klaus Gawrisch.Biophysical journal · 2023
    Article
  5. Article
  6. Recombinant Expression and Purification of Cannabinoid Receptor CBMethods in molecular biology (Clifton, N.J.) · 2021
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Alexei YeliseevLaboratory of Membrane Biochemistry and Biophysics, NIAAA, NIH, Bethesda, MD, Unites States. Electronic address: yeliseeva@mail.nih.gov.
Klaus GawrischLaboratory of Membrane Biochemistry and Biophysics, NIAAA, NIH, Bethesda, MD, Unites States. Electronic address: klausg@mail.nih.gov.
National Institutes of Health · US

Funding

NMR Investigations Of Cell Membrane StructureZIAAA000003 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI GAWRISCH, KLAUS · 2009 to 2020
$23.2M
NMR INVESTIGATIONS OF CELL MEMBRANE STRUCTUREZ01AA000003 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI GAWRISCH, KLAUS · 1993 to 2008
$5.4M
Intramural NIH HHS Z01 AA000003
6 · The paper itself

Abstract

Cannabinoid receptor type II (CB

Indexed as

Chromatography, AffinityCulture MediaEscherichia coliFermentationGene ExpressionHumansIsotope LabelingNuclear Magnetic Resonance, BiomolecularReceptor, Cannabinoid, CB2Recombinant Fusion ProteinsCulture MediaReceptor, Cannabinoid, CB2Recombinant Fusion ProteinsAffinity purificationBacterial fermentationCannabinoid receptor CB(2)G protein-coupled receptorNuclear magnetic resonanceRecombinant proteinStable isotope labeling

Identifiers

PMID28750812
PMCPMC6152942
OpenAlexW2734470663

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.